These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7174860)

  • 1. Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Parikh MD; Rathi LG; Ghandi MH; Parikh RM; Thatte S; Bharadwaj J
    J Clin Psychopharmacol; 1982 Dec; 2(6):376-9. PubMed ID: 7174860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoclopramide and haloperidol in tardive dyskinesia.
    Bateman DN; Dutta DK; McClelland HA; Rawlins MD
    Br J Psychiatry; 1979 Dec; 135():505-8. PubMed ID: 43755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA; Costa G; Bond G; Abu-Elmagd KM
    Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crossover study of lecithin treatment of tardive dyskinesia.
    Gelenberg AJ; Dorer DJ; Wojcik JD; Falk WE; Brotman AW; Leahy L
    J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Simpson GM; Yadalam KG; Stephanos MJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoclopramide treatment of tardive dyskinesia.
    Karp JM; Perkel MS; Hersh T; McKinney AS
    JAMA; 1981 Oct 23-30; 246(17):1934-5. PubMed ID: 7288971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a primate model for tardive dyskinesia.
    Bárány S; Häggström JE; Gunne LM
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.